Page last updated: 2024-08-23

zidovudine and Prostatic Neoplasms

zidovudine has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lavie, A; Medin, JA; Neschadim, A; Sato, T; Yanagisawa, T1
Burdick, R; Chaipan, C; Delviks-Frankenberry, KA; Hu, WS; Paprotka, T; Pathak, VK; Venkatachari, NJ1

Other Studies

2 other study(ies) available for zidovudine and Prostatic Neoplasms

ArticleYear
The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Analysis of Variance; Apoptosis; Bystander Effect; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Genes, Transgenic, Suicide; Genetic Therapy; HEK293 Cells; Humans; Male; Microscopy, Confocal; Nucleoside-Phosphate Kinase; Prodrugs; Prostatic Neoplasms; Reactive Oxygen Species; Zidovudine

2013
Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
    Journal of virology, 2010, Volume: 84, Issue:11

    Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cytidine Deaminase; Gammaretrovirus; Humans; Leukemia Virus, Murine; Male; Mice; Mutation; Organophosphonates; Prostatic Neoplasms; Pyrrolidinones; Raltegravir Potassium; Retroviridae Infections; Tenofovir; Tumor Virus Infections; Zidovudine

2010